Global Newborn Screening Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Newborn Screening Market is presumed to reach the market size of nearly USD 1769.97 Million by 2032 from USD 881.01 Million in 2023 with a CAGR of 8.06% under the study period 2024-2032.

Newborn screening is a health checkup done on every infant to test for a group of health disorders using a small blood test. During a checkup, doctors check for rare genetic, hormone-related, and metabolic conditions that can cause serious health problems. It includes more than 44 severe disorders that may be uncommon. Newborn screenings are performed before there are any observable symptoms on the baby. It allows conditions to be identified and treated before the occurrence of the problem.

MARKET DYNAMICS

The global newborn screening market is forecasted to grow with increasing new births, increasing prevalence of newborn disorders, rising deaths of newborn babies, expanding newborn babies services, and favorable policies. According to World Health Organization, around 41% of all under-5 child deaths are among newborn infants annually. Babies die in their first 28 days of life or the neonatal period. The growing numbers of deaths of newborn babies and the rising prevalence of newborn diseases have caused a rise in awareness and availability of advanced screening instruments. However, low awareness and lack of skilled expertise to perform screening processes are hampering the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Newborn Screening. The growth and trends of Newborn Screening industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Newborn Screening market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Tandem Mass Spectrometry
Pulse Oximetry
Enzyme-based Assay
DNA Assays
Electrophoresis
Others

By Test Type

Dry Blood Spot Test
CCHD
Hearing Screen

By Product

Instruments
Reagents

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Newborn Screening market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Newborn Screening market include Agilent Technologies Inc., AB SCIEX, Natus Medical Inc., Covidien Plc, Trivitron Healthcare, GE Lifesciences, Masimo, Waters Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11215084

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. NEWBORN SCREENING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Test Type
- 3.7.3 Market Attractiveness Analysis By Product
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL NEWBORN SCREENING MARKET ANALYSIS BY TECHNOLOGY

5.1. Overview By Technology
5.2. Historical and Forecast Data
5.3. Analysis By Technology
5.4. Tandem Mass Spectrometry Historic and Forecast Sales By Regions
5.5. Pulse Oximetry Historic and Forecast Sales By Regions
5.6. Enzyme-based Assay Historic and Forecast Sales By Regions
5.7. DNA Assays Historic and Forecast Sales By Regions
5.8. Electrophoresis Historic and Forecast Sales By Regions
5.9. Others Historic and Forecast Sales By Regions

6. GLOBAL NEWBORN SCREENING MARKET ANALYSIS BY TEST TYPE

6.1. Overview By Test Type
6.2. Historical and Forecast Data
6.3. Analysis By Test Type
6.4. Dry Blood Spot Test Historic and Forecast Sales By Regions
6.5. CCHD Historic and Forecast Sales By Regions
6.6. Hearing Screen Historic and Forecast Sales By Regions

7. GLOBAL NEWBORN SCREENING MARKET ANALYSIS BY PRODUCT

7.1. Overview By Product
7.2. Historical and Forecast Data
7.3. Analysis By Product
7.4. Instruments Historic and Forecast Sales By Regions
7.5. Reagents Historic and Forecast Sales By Regions

8. GLOBAL NEWBORN SCREENING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE NEWBORN SCREENING COMPANIES

9.1. Newborn Screening Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF NEWBORN SCREENING INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Agilent Technologies Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. AB SCIEX
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Natus Medical Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Covidien Plc
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Trivitron Healthcare
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. GE Lifesciences
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Masimo
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Waters Corporation
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. PerkinElmer Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Bio-Rad Laboratories Inc
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies